Oral Orforglipron Yields Greater Weight Reductions Than Placebo
Significant mean change in body weight from baseline to week 72 seen with various dosages of orforglipron compared with placebo among adults with obesity
Oral Semaglutide Effective for Weight Loss in Overweight or Obesity
Estimated mean change in body weight from baseline to week 64 was −13.6 and −2.2 percent with oral semaglutide and placebo, respectively
Psilocybin-Assisted Therapy Aids Symptoms of Major Depressive Disorder
Study shows sustained remission five years posttreatment
Measles Outbreak Spreads in Arizona-Utah Border Communities
Utah has reported 27 cases so far; Arizona has 42 confirmed cases, including one child who has been hospitalized
FDA Grants Accelerated Approval for First Treatment for Barth Syndrome
Forzinity helps improve strength of muscle to straighten the leg and works by improving mitochondria structure and function
Age at Start of Estrogen Therapy May Affect Alzheimer Disease Risk
Up to 32 percent lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women
FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis
Efficacy and safety found to be similar to intravenous induction
Declines Seen in New, Additional Prescribing of Opioids in Patients With Cancer
New opioid prescribing was stable for patients with metastatic cancer with pain and declined for those reporting no pain
Trump Links Tylenol, Vaccines to Autism Without Evidence, Experts Say
Experts contend autism diagnoses have risen mainly because the definition of autism has expanded, awareness of the condition has grown
GLP-1 Receptor Agonists Improve Glycemic, Weight Outcomes in Children With T2D
Glycemic, weight, cardiometabolic outcomes improved for children and teens with obesity, prediabetes, or T2D
